Thiazide‑Induced Hyponatremia: Mechanisms and Clinical Management

Pathophysiology

Mild volume depletion caused by thiazide diuretics stimulates a hypovolemia‑driven increase in proximal sodium and water reabsorption, thereby reducing the amount of fluid reaching the distal diluting segment of the nephron. This impaired delivery limits the kidney’s ability to generate maximally dilute urine and contributes to hyponatremia development. 1, 2, 3
The volume‑depleted state also lowers glomerular filtration rate and enhances proximal reabsorption, further decreasing fluid flow to the distal nephron where dilution normally occurs. This compounded reduction in distal delivery exacerbates the dilution defect. 1, 2, 3

Hyponatremia most often appears within the first 2 weeks after starting a thiazide, with the largest serum‑sodium declines occurring during the first 3 days of therapy. 4

When correcting thiazide‑induced hyponatremia, the rise in serum sodium should be limited to ≤ 8 mmol/L in any 24‑hour period to avoid osmotic demyelination syndrome. 4
Electrolyte panels (including sodium) should be obtained 2–4 weeks after thiazide initiation or after any dose escalation, recognizing that clinically significant shifts can already be present by day 3. 4, 5
The KDOQI (Kidney Disease Outcomes Quality Initiative) guidelines advise checking both electrolytes and estimated glomerular filtration rate (eGFR) within 4 weeks of starting a thiazide diuretic. 4
Older adults warrant more frequent laboratory monitoring because they have a higher propensity for severe hyponatremia and related neurological complications. 4, 5